Pre-Open Stock Stock Movers:

Marathon Digital Holdings, Inc. (NASDAQ: MARA) 17.4% LOWER; Bitcoin, cryptos crash

Riot Blockchain, Inc. (NASDAQ: RIOT) 16.8% LOWER; Bitcoin, cryptos crash

LightPath Technologies, Inc. (NASDAQ: LPTH) 16.2% HIGHER; announced that NASA's Jet Propulsion Laboratory (JPL) recently confirmed that optical elements manufactured by our subsidiary, ISP Optics, is supporting the Mars Curiosity Rover's efforts in the NASA Science Exploration Program.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) 13.2% HIGHER; Received a communication from the Division of Neurology Products 1 (Division) of the U.S. Food and Drug Administration (FDA) stating that, after a preliminary review of briefing materials for an upcoming Type C meeting, a pre-NDA meeting is the most appropriate format for a discussion of the development program for omaveloxolone in Friedreichs ataxia (FA). The Division suggested that the Company withdraw the current meeting request for a Type C meeting and instead request a pre-NDA meeting, which the Division will grant upon receipt. The Division asked the Company to focus the new briefing package on questions, issues, and needs applicable to a pre-NDA meeting. As requested by the FDA, the Company plans to withdraw the current request for a Type C meeting and submit a request for a pre-NDA meeting as soon as practicable.

MicroStrategy Incorporated (NASDAQ: MSTR) 12.9% LOWER; Bitcoin, cryptos crash

Coinbase Global, Inc. (NASDAQ: COIN) 9.7% LOWER; Bitcoin, cryptos crash

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) 9% LOWER; announced receipt of regulatory feedback from the U.S. Food and Drug Administration (FDA) regarding its potency assays for lifileucel. Previously, the company reported the submission of assay data to the FDA and recently the FDA provided comments regarding the data package.

Quicklogic Corp (NASDAQ: QUIK) 7% LOWER; reported Q1 EPS of ($0.12), $0.05 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.5 million.

Purple Innovation, Inc. (NASDAQ: PRPL) 6.9% LOWER; announced the launch of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC – Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The underwriters have a 30-day option period to purchase up to 1,096,318 additional shares of Class A common stock from the Selling Stockholders.

Lithia Motors & Driveway (NYSE: LAD) 4.5% LOWER; today announced that we intend to offer, subject to market and other conditions, $1 billion of shares of our Class A common stock in a public offering (the "Offering"). In addition, we intend to grant the underwriters a 30-day option to purchase up to an additional $150 million of shares of common stock. Lithia intends to use the net proceeds of the Offering for general corporate purposes, which may include financing possible acquisitions, repaying or refinancing debt, working capital and capital expenditures.

Take-Two Interactive Software (NASDAQ: TTWO) 2.1% HIGHER; reported Q4 EPS of $1.40, $0.74 better than the analyst estimate of $0.66. Revenue for the quarter came in at $784.5 million versus the consensus estimate of $663.84 million. Take-Two Interactive Software sees Q1 2022 EPS of $0.75-$0.85. Take-Two Interactive Software sees Q1 2022 revenue of $625-675 million. Take-Two Interactive Software sees FY2022 EPS of $3.75-$4.00. Take-Two Interactive Software sees FY2022 revenue of $3.2-3.3 billion.

Lowe's Cos. (NYSE: LOW) 2% LOWER; reported Q1 EPS of $3.21, $0.65 better than the analyst estimate of $2.56. Revenue for the quarter came in at $24.42 billion versus the consensus estimate of $23.46 billion. Consolidated Comparable Sales Increased 25.9%; U.S. Comparable Sales Increased 24.4%.

Target (NYSE: TGT) 1.8% HIGHER; reported Q1 EPS of $3.69, $1.54 better than the analyst estimate of $2.15. Revenue for the quarter came in at $24.2 billion versus the consensus estimate of $21.48 billion. First quarter comparable sales grew 22.9 percent, on top of 10.8 percent growth last year.